Yibin Kang
Impact in
- Cancer Research top 0.05%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.05%
- Cancer Cells and Metastasis
- Bone health and treatments
Papers in
-
- TGF-β signaling in diseases 19
- Epigenetics and DNA Methylation 16
- RNA Research and Splicing 15
- Oncology 102
- Cancer Cells and Metastasis 55
- Bone health and treatments 22
- Peptidase Inhibition and Analysis 18
- Co-authors
- Joan Massagué (14 shared papers)Xin Lü (18 shared papers)Manav Korpal (5 shared papers)Guohong Hu (11 shared papers)Klaus Pantel (5 shared papers)Yong Wei (36 shared papers)Wei Lu (2 shared papers)Chang-Rung Chen (4 shared papers)
- Journals
- Cancer Research (11 papers)Genes & Development (10 papers)Journal of Biological Chemistry (10 papers)Cancer Cell (9 papers)Proceedings of the National Academy of Sciences (7 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Yibin Kang
189 papers receiving 25.3k citations
Yibin Kang's Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 7.5k
- Oncology 10.2k
- Molecular Biology 14.3k
- Immunology and Allergy 728
- Immunology 2.3k
Countries citing papers authored by Yibin Kang
This map shows the geographic impact of Yibin Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibin Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibin Kang more than expected).
Fields of papers citing papers by Yibin Kang
This network shows the impact of papers produced by Yibin Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibin Kang. The network helps show where Yibin Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yibin Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A multigenic program mediating breast cancer metastasis to bone Hit paper breakdown → | 2003 | 1978 |
| 2 | Pre-metastatic niches: organ-specific homes for metastases Hit paper breakdown → | 2017 | 1387 |
| 3 | The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2 Hit paper breakdown → | 2008 | 1359 |
| 4 | Epithelial-Mesenchymal Transitions Hit paper breakdown → | 2004 | 1243 |
| 5 | Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis Hit paper breakdown → | 2019 | 749 |
| 6 | Tumor metastasis: moving new biological insights into the clinic Hit paper breakdown → | 2013 | 625 |
| 7 | Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis Hit paper breakdown → | 2010 | 560 |
| 8 | Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors Hit paper breakdown → | 2005 | 523 |
| 9 | Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization Hit paper breakdown → | 2011 | 512 |
| 10 | 2006 | 485 | |
| 11 | 2011 | 453 | |
| 12 | 2003 | 440 | |
| 13 | Context-dependent EMT programs in cancer metastasis Hit paper breakdown → | 2019 | 429 |
| 14 | 2005 | 418 | |
| 15 | VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors Hit paper breakdown → | 2011 | 403 |
| 16 | 2002 | 389 | |
| 17 | 2009 | 343 | |
| 18 | 2014 | 337 | |
| 19 | 2016 | 333 | |
| 20 | 2013 | 327 |
About Yibin Kang
Yibin Kang is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 192 papers that have together received 25.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (55 papers), Bone health and treatments (22 papers), TGF-β signaling in diseases (19 papers), Peptidase Inhibition and Analysis (18 papers), Cancer Mechanisms and Therapy (17 papers), Epigenetics and DNA Methylation (16 papers), RNA Research and Splicing (15 papers) and MicroRNA in disease regulation (14 papers). The work is most often cited by research in Cancer Research (7.5k citations), Oncology (10.2k citations), Molecular Biology (14.3k citations), Immunology and Allergy (728 citations) and Immunology (2.3k citations). Yibin Kang has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Joan Massagué, Xin Lü, Manav Korpal, Guohong Hu, Klaus Pantel, Yong Wei, Wei Lu, Chang-Rung Chen, Peter M. Siegel and Nilay S. Sethi. Their work appears in journals such as Cancer Research, Genes & Development, Journal of Biological Chemistry, Cancer Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.